László Váróczy

628 total citations
47 papers, 425 citations indexed

About

László Váróczy is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, László Váróczy has authored 47 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 18 papers in Hematology and 14 papers in Oncology. Recurrent topics in László Váróczy's work include Lymphoma Diagnosis and Treatment (18 papers), Multiple Myeloma Research and Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). László Váróczy is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Multiple Myeloma Research and Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). László Váróczy collaborates with scholars based in Hungary, Norway and United States. László Váróczy's co-authors include Árpád Illés, Lajos Gergely, Margit Zeher, Gyula Szegedi, Zsófia Miltényi, Péter Szodoray, Sándor Sipka, Éva Remenyik, Katalin Keresztes and Zoltán Szekanecz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Electrophoresis.

In The Last Decade

László Váróczy

39 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Váróczy Hungary 13 223 127 89 85 64 47 425
T. P. Vassilakopoulos Greece 12 271 1.2× 166 1.3× 81 0.9× 160 1.9× 65 1.0× 19 502
Guido Gini Italy 12 241 1.1× 93 0.7× 104 1.2× 210 2.5× 184 2.9× 37 629
M. Dorreen United Kingdom 13 178 0.8× 74 0.6× 80 0.9× 151 1.8× 43 0.7× 23 390
Anjum Hassan United States 16 220 1.0× 93 0.7× 88 1.0× 168 2.0× 114 1.8× 39 540
Sotirios Sachanas Greece 12 209 0.9× 158 1.2× 43 0.5× 146 1.7× 109 1.7× 34 384
Ho Young Kim South Korea 11 98 0.4× 83 0.7× 37 0.4× 94 1.1× 97 1.5× 34 414
Laurence Sanhès France 10 125 0.6× 217 1.7× 88 1.0× 101 1.2× 167 2.6× 24 475
Renato Scalone Italy 11 245 1.1× 66 0.5× 67 0.8× 151 1.8× 121 1.9× 17 455
Mariko Yabe United States 14 199 0.9× 138 1.1× 113 1.3× 142 1.7× 128 2.0× 39 466

Countries citing papers authored by László Váróczy

Since Specialization
Citations

This map shows the geographic impact of László Váróczy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Váróczy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Váróczy more than expected).

Fields of papers citing papers by László Váróczy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Váróczy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Váróczy. The network helps show where László Váróczy may publish in the future.

Co-authorship network of co-authors of László Váróczy

This figure shows the co-authorship network connecting the top 25 collaborators of László Váróczy. A scholar is included among the top collaborators of László Váróczy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Váróczy. László Váróczy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Szász, Róbert, et al.. (2024). The efficacy and safety of second salvage autologous transplantation in myeloma patients. Pathology & Oncology Research. 30. 1611851–1611851.
4.
Szekanecz, Zoltán, Boglárka Soós, Levente Bodoki, et al.. (2020). Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. Autoimmunity Reviews. 19(11). 102658–102658. 14 indexed citations
5.
Varga, Gergely, Zsolt Nagy, Judit Demeter, et al.. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. Pathology & Oncology Research. 25(4). 1615–1620. 17 indexed citations
6.
Miltényi, Zsófia, et al.. (2014). Histopathological Difficulties in an Adolescent Lymphoma Patient. Pathology & Oncology Research. 21(1). 213–217. 3 indexed citations
7.
Váróczy, László, Erika Zilahi, Ágnes Gyetvai, et al.. (2011). Fc-Gamma-Receptor IIIa Polymorphism and Gene Expression Profile Do Not Predict the Prognosis in Diffuse Large B-cell Lymphoma Treated with R-CHOP Protocol. Pathology & Oncology Research. 18(1). 43–48. 19 indexed citations
8.
Müller, Judit, Árpád Illés, Zsuzsanna Molnár, et al.. (2011). Adolescent Hodgkin Lymphoma. Journal of Pediatric Hematology/Oncology. 33(2). e60–e63. 18 indexed citations
9.
Szodoray, Péter, László Váróczy, Gábor Papp, et al.. (2011). Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases. Scandinavian Journal of Rheumatology. 41(2). 110–115. 26 indexed citations
10.
Szántó, Antónia, et al.. (2011). Hodgkin’s Lymphoma Developed after Autologous Stem Cell Transplantation for Multiple Myeloma. Pathology & Oncology Research. 18(3). 733–736. 1 indexed citations
11.
Váróczy, László, et al.. (2011). Malignant lymphomas and autoimmunity—a single center experience from Hungary. Clinical Rheumatology. 31(2). 219–224. 13 indexed citations
12.
13.
Szodoray, Péter, László Váróczy, G. Szegedi, & Margit Zeher. (2010). Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. Scandinavian Journal of Rheumatology. 39(1). 1–11. 13 indexed citations
14.
Illés, Árpád, László Váróczy, Gábor Papp, et al.. (2009). Aspects of B‐Cell Non‐Hodgkin’s Lymphoma Development: A Transition from Immune‐Reactivity to Malignancy. Scandinavian Journal of Immunology. 69(5). 387–400. 18 indexed citations
15.
Váróczy, László, et al.. (2006). Malignant lymphomas in the elderly: A single institute experience highlights future directions. Archives of Gerontology and Geriatrics. 45(1). 43–53. 2 indexed citations
16.
Váróczy, László, et al.. (2006). Uncommon lymphadenopathies of immunopathogenesis can be misinterpreted as malignant diseases. Rheumatology International. 27(8). 753–757. 1 indexed citations
17.
Gergely, Lajos, Magdolna Aleksza, László Váróczy, et al.. (2004). Intracellular IL‐4/IFN‐gamma producing peripheral T lymphocyte subsets in B cell non‐Hodgkin's lymphoma patients. European Journal Of Haematology. 72(5). 336–341. 11 indexed citations
18.
Váróczy, László, Lajos Gergely, Zsófia Miltényi, Magdolna Aleksza, & Árpád Illés. (2004). Can CD3+/HLA-DR+ activated T cells predict the prognosis of non-Hodgkin's lymphoma patients?. Immunology Letters. 97(1). 155–157. 10 indexed citations
19.
Gergely, Lajos, et al.. (2003). Successful Treatment of B Cell Chronic Lymphocytic Leukemia-Associated Severe Paraneoplastic Pemphigus with Cyclosporin A. Acta Haematologica. 109(4). 202–205. 29 indexed citations
20.
Illés, Árpád, Zsófia Miltényi, Katalin Keresztes, et al.. (2002). Hypothyroidism and Thyroiditis after Therapy for Hodgkin’s Disease. Acta Haematologica. 109(1). 11–17. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026